The ADVOS (Advanced Organ Support) procedure is designed to provide multi-organ support for liver, lungs, and kidneys and correction of acid-base balance disorders.
The ADVOS device represents an evolution from conventional dialysis machines, as it uses protein enriched instead of regular dialysis water and allows targeted manipulation of dialysis fluid pH. Within the device, the dialysis fluid is permanently reprocessed and cleared of toxins to maintain a constantly high detoxification performance. The ADVOS procedure is successfully in use in a large number of German university hospitals.
- Press Release
We are very proud to be among the very few selected companies being beneficiaries of the EIC Accelerator Pilot blended Finance support! This is not only a great seal of excellence for our first class innovation but also provides growth capital necessary to further bring our unique 4-in-1 Organ Support Therapy ADVOS into the world. Our ADVOS multi organ support device combines liver, kidney and lungs support as well as fast blood pH correction and can improve patient survival on the intensive care unit from 20% upto 50%.
Our experience with the EIC Fund has been very positive. The grant signature preparation and project supervision were transparent and smooth as well as the due diligence as preparation for the equity investment. Any company supported by the EIC Fund is can consider themselves as fortunate to be part of an outstanding community. Personally, I also highly benefited from the EIC Women Leadership Mentoring program 2021: The EIC program combines high class mentoring with tailored business coaching and valuable networking training events fostering women entrepreneurship in the EU.
Catherine Schreiber, Deputy CEO